All G Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10M
- Investors
-
17
All G General Information
Description
Developer of recombinant human and bovine milk proteins designed for business-to-business supply to the infant formula industry. The company's pipeline includes high-value proteins such as lactoferrin and other bio-equivalent components of human milk, supported by proprietary intellectual property and scalable casein micelle technology, enabling infant formula producers to align protein profiles more closely with human breast milk and expand applications in advanced nutrition.
Contact Information
Website
www.allg.comCorporate Office
- T15A & 15C, Level 2 409 George Street
- Waterloo, New South Wales 2017
- Australia
Corporate Office
- T15A & 15C, Level 2 409 George Street
- Waterloo, New South Wales 2017
- Australia
All G Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 21-Jan-2026 | $10M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 04-Aug-2022 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
All G Comparisons
Industry
Financing
Details
All G Competitors (3)
One of All G’s 3 competitors is Eclipse Ingredients, a Venture Capital-Backed company based in Brisbane, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eclipse Ingredients | Venture Capital-Backed | Brisbane, Australia | ||||
| TurtleTree | Venture Capital-Backed | Singapore, Singapore | ||||
| Helaina | Venture Capital-Backed | New York, NY |
All G Patents
All G Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250344719-A1 | Compositions | Pending | 30-May-2022 |
All G Signals
All G Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ID Capital | Venture Capital | Minority | ||
| Opus8 | PE/Buyout | Minority | ||
| Thunderbolt Capital | Venture Capital | Minority | ||
| Xeraya Capital | Venture Capital | Minority | ||
| Agronomics | Venture Capital | Minority |
All G Investments (1)
All G’s most recent deal was a Joint Venture with JV (All G / Armor Protéines). The deal was made on 08-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| JV (All G / Armor Protéines) | 08-Dec-2025 | Joint Venture | Food Products |
All G FAQs
-
When was All G founded?
All G was founded in 2020.
-
Where is All G headquartered?
All G is headquartered in Waterloo, Australia.
-
What is the size of All G?
All G has 48 total employees.
-
What industry is All G in?
All G’s primary industry is Biotechnology.
-
Is All G a private or public company?
All G is a Private company.
-
What is All G’s current revenue?
The current revenue for All G is .
-
How much funding has All G raised over time?
All G has raised $42.2M.
-
Who are All G’s investors?
ID Capital, Opus8, Thunderbolt Capital, Xeraya Capital, and Agronomics are 5 of 17 investors who have invested in All G.
-
Who are All G’s competitors?
Eclipse Ingredients, TurtleTree, and Helaina are competitors of All G.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process